Psychiatric Comorbidities in Children with Attention Deficit Hyperactivity Disorder: Implications for Management

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.5, Iss.11, 2003-01, pp. : 741-750

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comorbidities and Costs of Adult Patients Diagnosed with Attention-Deficit Hyperactivity Disorder

By Kristina Secnik Andrine Swensen Maureen J. Lage

PharmacoEconomics, Vol. 23, Iss. 1, 2005-01 ,pp. : 93-102

Adis International

Access to resources Recommend Favorite

Pharmacological management of attention-deficit hyperactivity disorder

By Reeves Gloria Schweitzer Julie

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1313-1320

Informa Healthcare

Access to resources Recommend Favorite

Attention-Deficit Hyperactivity Disorder in Girls: Epidemiology and Management

By Staller Jud Faraone Stephen V.

CNS Drugs, Vol. 20, Iss. 2, 2006-01 ,pp. : 107-123

Adis International

Access to resources Recommend Favorite

Role of Zinc in the Pathogenesis of Attention-Deficit Hyperactivity Disorder: Implications for Research and Treatment

By Lepping Peter

CNS Drugs, Vol. 24, Iss. 9, 2010-09 ,pp. : 721-728

Adis International

Access to resources Recommend Favorite

Substance Abuse in Patients with Attention-Deficit Hyperactivity Disorder: Therapeutic Implications

By Schubiner Howard

CNS Drugs, Vol. 19, Iss. 8, 2005-01 ,pp. : 643-655

Adis International

Access to resources Recommend Favorite